December 10th & 11th, 2026
15th edition
MARSEILLE, FR

Taking the right fork in the road: What are the criteria to choose between out-licensing vs. creating a company?

Edition

Taking the right fork in the road: What are the criteria to choose between out-licensing vs. creating a company?

How to valuate and make your project out? What are the best options among licensing, corporating or creating a start-up? On which grounds are TTOs advising to create a spin-off rather than out-licensing the IP or a contract-based R&D collaboration? What each of these alternatives entail? What kind of surroundings would you need for each of these options?

Jérôme Van Biervliet

Managing Director
VIB

Lisa Urquhart

Editor
Evaluate Vantage

Bobby Soni

Chief Business Officer
BioInnovation Institute

Jason Mellad

CEO and Co-Founder
Start Codon

Laetitia Szaller

General Counsel & VP Business Development
AM Pharma

Tony Hickson

Chief Business Officer
Cancer Research UK
Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.